ArticleNeurology2025
Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis.
Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- External validation of KFLC index threshold for multiple sclerosis diagnosis in a French cohort.Journal of neurology · 2026Article
- Intrathecal immunoglobulin production in the diagnosis, prognosis, and monitoring of autoimmune diseases of the central nervous system.Journal of translational autoimmunity · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesKappa-free light chain (κ-FLC) is a quantitative biomarker of intrathecal immunoglobulin synthesis, with diagnostic accuracy comparable to oligoclonal bands in patients with multiple sclerosis (pwMS). However, their association with longitudinal brain MRI parameters remains unclear. We investigated associations between κ-FLC and MRI metrics in pwMS.
methodsIn this retrospective cohort study, serum and CSF samples were collected from pwMS with brain MRI performed ≥1 year after lumbar puncture at the Medical University of Graz between 2005 and 2020. κ-FLC concentrations were quantified in paired serum and CSF samples using the Optilite turbidimeter; κ-FLC index was calculated as ratio of the quotient of κ-FLC to albumin. MS lesions were segmented on FLAIR images using the lesion prediction algorithm of SPM's LST toolbox, categorized into periventricular lesions (PVLs) and non-PVLs. We assessed association of κ-FLC with lesion types, hypothesizing their contribution to damage in CSF-proximal regions. Brain volumes (gray, subcortical gray and white matter) and mean cortical thickness were estimated with FreeSurfer v.6.0.
resultsA total of 109 participants were included (66% female, mean age 33.0 ± 9.5 years). Those with κ-FLC index ≥ median showed significantly higher PVL load (median: 3.2 cm DISCUSSION: Higher κ-FLC levels were associated with both PVL burden and cortical pathology, regions adjacent to the CSF. Although this study was limited by a relative small sample size, our findings underscore the potential of κ-FLC as a diagnostic and prognostic MS biomarker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.